STIFEL FINANCIAL CORP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$169,158
-48.1%
25,323
-34.8%
0.00%
Q2 2023$325,673
+18.9%
38,817
+40.8%
0.00%
Q1 2023$273,840
+163.6%
27,577
+84.7%
0.00%
Q4 2022$103,899
+22.2%
14,928
-6.3%
0.00%
Q3 2022$85,000
+9.0%
15,928
-18.2%
0.00%
Q2 2022$78,000
-29.1%
19,463
-21.3%
0.00%
Q1 2022$110,000
-20.3%
24,742
-28.4%
0.00%
Q4 2021$138,000
-77.2%
34,577
-49.7%
0.00%
-100.0%
Q3 2021$604,000
-4.4%
68,788
+23.3%
0.00%0.0%
Q2 2021$632,000
-19.6%
55,797
-15.7%
0.00%0.0%
Q1 2021$786,000
+25.6%
66,191
-27.4%
0.00%0.0%
Q4 2020$626,000
-12.1%
91,201
-5.0%
0.00%0.0%
Q3 2020$712,000
+49.3%
96,031
-16.0%
0.00%0.0%
Q2 2020$477,000
+183.9%
114,373
+65.3%
0.00%
Q1 2020$168,000
-63.6%
69,210
-12.8%
0.00%
-100.0%
Q4 2019$461,000
+236.5%
79,336
+204.0%
0.00%
Q3 2019$137,000
-55.8%
26,100
-49.4%
0.00%
-100.0%
Q2 2019$310,000
+103.9%
51,549
+212.1%
0.00%
Q1 2019$152,000
+72.7%
16,519
+53.6%
0.00%
Q4 2018$88,000
-54.4%
10,754
-22.9%
0.00%
-100.0%
Q3 2018$193,000
+127.1%
13,954
+32.7%
0.00%
Q2 2018$85,000
+7.6%
10,517
+1.4%
0.00%
Q1 2018$79,00010,3670.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders